Literature DB >> 7681860

In vitro detection of glycoprotein production and secretion by human nonfunctioning pituitary adenomas.

K Saccomanno1, P Gil del Alamo, M Bassetti, F Reza-Elahi, A Spada.   

Abstract

This study, carried out on 9 nonfunctioning pituitary adenomas, was undertaken in order to evaluate the ability of these tumors to synthesize and release gonadotropins and/or free alpha-subunit (alpha-SU) of glycoproteins. The morphological study included electron microscopy and immunofluorescence analysis while hormone release was evaluated by the reverse hemolytic plaque assay (RHPA) and measurements in culture media. By electron microscopy in all tumors (6 null cell adenomas and 3 oncocytomas), it was possible to identify rough endoplasmic reticulum, Golgi apparatus and secretory granules. By immunofluorescence, 5 of 6 tumors were immunoreactive for one or more gonadotropin subunits; in particular, 5 adenomas were positive for alpha-SU and LH-beta, and 3 for FSH-beta. By the RHPA, about 1% of cells obtained from one single tumor formed plaques for LH-beta and alpha-SU while the remaining tumors were negative. Similarly, the study of media concentrations of LH, FSH and alpha-SU in 2 h culture revealed very low amounts of released hormones. In these experimental conditions no modification was observed after the addition of stimulatory agents such as TRH, GnRH and VIP. The present study clearly indicates that although the large majority of nonfunctioning tumors are positive for gonadotropins their secretory capacity is very low in both basal and stimulated conditions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681860     DOI: 10.1007/bf03347659

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Subpopulations of lactotropes detected with the reverse hemolytic plaque assay show differential responsiveness to dopamine.

Authors:  E H Luque; M Munoz de Toro; P F Smith; J D Neill
Journal:  Endocrinology       Date:  1986-05       Impact factor: 4.736

2.  Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas.

Authors:  S L Asa; B M Gerrie; W Singer; E Horvath; K Kovacs; H S Smyth
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

3.  Morphological studies on mixed growth hormone (GH)- and prolactin (PRL)-secreting human pituitary adenomas. Coexistence of GH and PRL in the same secretory granule.

Authors:  M Bassetti; A Spada; M Arosio; L Vallar; M Brina; G Giannattasio
Journal:  J Clin Endocrinol Metab       Date:  1986-06       Impact factor: 5.958

4.  Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine.

Authors:  D J Kwekkeboom; F H de Jong; S W Lamberts
Journal:  J Clin Endocrinol Metab       Date:  1989-06       Impact factor: 5.958

5.  Secretion of LH, FSH, and PRL shown by cell culture and immunocytochemistry of human functionless pituitary adenomas.

Authors:  K Mashiter; E Adams; S Van Noorden
Journal:  Clin Endocrinol (Oxf)       Date:  1981-08       Impact factor: 3.478

6.  Gonadotrophin and alpha subunit secretion by human 'functionless' pituitary adenomas in cell culture: long term effects of luteinizing hormone releasing hormone and thyrotrophin releasing hormone.

Authors:  D W Surmont; C L Winslow; M Loizou; M C White; E F Adams; K Mashiter
Journal:  Clin Endocrinol (Oxf)       Date:  1983-09       Impact factor: 3.478

7.  Analysis of mammosomatotropic cells in normal and neoplastic human pituitary tissues by the reverse hemolytic plaque assay and immunocytochemistry.

Authors:  R V Lloyd; D Anagnostou; M Cano; A L Barkan; W F Chandler
Journal:  J Clin Endocrinol Metab       Date:  1988-06       Impact factor: 5.958

8.  In vitro effect of dopamine on growth hormone (GH) release from human GH-secreting pituitary adenomas.

Authors:  A Spada; A Sartorio; M Bassetti; G Pezzo; G Giannattasio
Journal:  J Clin Endocrinol Metab       Date:  1982-10       Impact factor: 5.958

9.  Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone.

Authors:  L J Hofland; P M van Koetsveld; C C van Vroonhoven; S Z Stefanko; S W Lamberts
Journal:  J Clin Endocrinol Metab       Date:  1989-03       Impact factor: 5.958

10.  Glycoprotein hormone alpha-subunit secretion in patients with pituitary adenomas: influence of TRH, LRH and bromocriptine.

Authors:  I A MacFarlane; C G Beardwell; S M Shalet; G Ainslie; E Rankin
Journal:  Acta Endocrinol (Copenh)       Date:  1982-04
View more
  4 in total

1.  Immunohistochemical evaluation of the post-translational processing of chromogranin A in human pituitary adenomas.

Authors:  A P Heaney; W J Curry; K M Pogue; V L Armstrong; M Mirakhur; B Sheridan; C F Johnston; K D Buchanan; A B Atkinson
Journal:  Pituitary       Date:  2000-10       Impact factor: 4.107

2.  Differential regulation of gonadotropins and glycoprotein hormone alpha-subunit by IGF-I in anterior pituitary cells from male rats.

Authors:  F Pazos; F Sánchez-Franco; J Balsa; J Escalada; L Cacicedo
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

3.  Immunodetection of glycoprotein hormone subunits in nonfunctioning and glycoprotein hormone-secreting pituitary adenomas.

Authors:  K Saccomanno; M Bassetti; A Lania; M Losa; G Faglia; A Spada
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

4.  Abnormal transduction of dopamine signal in human nonfunctioning pituitary adenomas.

Authors:  A Lania; F Reza-Elahi; P Gil-del-Alamo; K Saccomanno; S Mantovani; A Spada
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.